You are here

Anticompetitive Patent Settlements and the Supreme Court’s Actavis Decision

Herb Hovenkamp

In this paper, Professor Hovenkamp explores the broad significance of the U.S. Supreme Court’s ruling in FTC v. Actavis, in which the Court held that it might violate the nation’s antitrust laws to settle a patent infringement suit in which the patentee of  a branded pharmaceutical drug pays a generic infringer to stay out of the market.  To read the paper, click here and then press the “download this paper” button.

News Section: 
Faculty Scholarship